|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 11, 895-901, Copyright © 1997 by European Association for Cardio-thoracic Surgery
VS Patel, B Radovancevic, W Springer, OH Frazier, E Massin, J Benrey, K Kadipasaoglu and DA Cooley
OBJECTIVE: To assess the efficacy of revascularization in cardiac
transplant patients who developed de novo coronary artery disease. METHODS:
Eighteen patients underwent one or more of four methods of
revascularization: percutaneous transluminal coronary angioplasty (PTCA),
percutaneous transluminal coronary rotational atherectomy (PTCRA), coronary
artery bypass grafting (CABG), and transmyocardial laser revacularization
(TMLR). Eleven PTCA procedures were performed in 10 patients 55.3 +/- 6.6
months after transplantation. Six patients underwent PTCRA 83.3 +/- 11.2
months after transplantation. Five patients underwent CABG 54.0 +/- 12.6
months after transplantation; the mean left ventricular ejection fraction
was 49.6 +/- 16.9 (20-65%); hypertrophy was present in two of these
patients. One patient with distal coronary artery disease and New York
Heart Association class IV symptoms underwent TMLR only. One patient
underwent both CABG and TMLR because of triple vessel proximal disease,
diffuse distal disease, and New York Heart Association class IV symptoms.
RESULTS: PTCA was successful in 10 procedures with decrease in mean
stenosis from 87.7 +/- 2.7 to 24.3 +/- 6.0%. Follow-up, at 16.9 +/- 4.0
months, showed restenosis in two patients. PTCRA was successful in all
patients with a decrease in mean stenosis from 83.4 +/- 4.4 to 11.7 +/-
1.9%. Short- term follow-up did not reveal reocclusion. Two CABG patients
who had hypertrophy died of heart failure 2 and 9 days after their
operations. One CABG patient with excellent cardiac function died after 15
days because of pulmonary failure. In one patient, left ventricular
ejection fraction improved from 35 to 50%, and he is alive 64 months later.
Six months after TMLR, the New York Heart Association class in one patient
improved from IV to II, and his left ventricular ejection fraction improved
from 29 to 42%. The ejection fraction in the patient who underwent both
CABG and TMLR improved from 20 to 56% but the patient expired 7 weeks
later. CONCLUSIONS: It appears that revascularization procedures can be
effective in patients with coronary artery disease after cardiac
transplantation and that coronary angioplasty or atherectomy would be a
therapy of choice for single proximal lesions. CABG should be used
cautiously and only reserved for patients with multi-vessel disease without
hypertrophy. Laser revascularization with or without bypass grafting has
potential to become the therapy of choice for transplant coronary artery
disease.
ARTICLES
Revascularization procedures in patients with transplant coronary artery disease
Texas Heart Institute at St. Luke's Epsicopal Hospital, Houston 77030, USA.
This article has been cited by other articles:
![]() |
D. Schmauss and M. Weis Cardiac Allograft Vasculopathy: Recent Developments Circulation, April 22, 2008; 117(16): 2131 - 2141. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Aleksic, J. A. Piotrowski, M. Kamler, U. Herold, and H. G. Jakob Minimally invasive direct coronary artery bypass in a cardiac transplant recipient with allograft vasculopathy Ann. Thorac. Surg., April 1, 2004; 77(4): 1433 - 1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347. [Full Text] [PDF] |
||||
![]() |
B. Lindelow, C.-H. Bergh, C. Lamm, B. Andersson, and F. Waagstein Graft coronary artery disease is strongly related to the aetiology of heart failure and cellular rejections Eur. Heart J., September 2, 1999; 20(18): 1326 - 1334. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |